eMedCodes logo

Exjade - deferasirox

Navigation: NDC > Supplier starting with: N > NOVARTIS PHARMACEUTICALS CORPORATION
Field Value
NDC Code: 0078-0468
Proprietary Name: Exjade
Suffix:
Non-Proprietary Name: deferasirox
Dosage Form: TABLET, FOR SUSPENSION
Method: ORAL
Original Marketing Date: 30-11-2005
Category Name: NDA
Application Number: NDA021882
Labeler: NOVARTIS PHARMACEUTICALS CORPORATION
Substance Name: DEFERASIROX
Active Numerator Strength: 125
Active Ingredient Unit: mg/1
Pharm Classes: Iron Chelating Activity [MoA],Iron Chelator [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA]
DEA Schedule: